Bristol-Myers Squibb Co (NYSE:BMY)
$ 44.94 0.2 (0.45%) Market Cap: 91.10 Bil Enterprise Value: 138.84 Bil PE Ratio: 0 PB Ratio: 5.52 GF Score: 83/100

Q3 2020 Bristol-Myers Squibb Co Earnings Call Transcript

Nov 05, 2020 / 01:30PM GMT
Release Date Price: $63.75 (-2.57%)
Operator

Good day, and welcome to the Bristol-Myers Squibb 2020 Third Quarter Results Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Mr. Tim Power, Vice President, Investor Relations. Please go ahead, sir.

Timothy Power
Bristol-Myers Squibb Company - VP & Head of IR

Thanks, Kevin, and good morning, everyone. Thanks for joining us this morning for our third quarter 2020 earnings call.

Joining me this morning with prepared remarks are Giovanni Caforio, our Board Chair and Chief Executive Officer; and David Elkins, our Chief Financial Officer. And also participating in today's call are Chris Boerner, our Chief Commercialization Officer; Nadim Ahmed, President, Hematology; and Samit Hirawat, our Chief Medical Officer and Head of Global Drug Development. As you note, we've posted slides to bms.com that you can follow along with Giovanni and David's remarks.

And before we get going, I'll read our forward-looking statements. During this call, we'll make statements about the company's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot